Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome
Miyakawa, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
1988
ISSN/ISBN: 0047-1852 PMID: 2975714 Document Number: 310649
Document emailed within 1 workday
Related Documents
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Narindrasorasak, S.; Altman, R.A.; Gonzalez-DeWhitt, P.; Greenberg, B.D.; Kisilevsky, R. 1995: An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease Laboratory Investigation; A Journal of Technical Methods and Pathology 72(3): 272-282
DE Felice, F.G.; Houzel, J-Christophe.; Garcia-Abreu, Jé.; Louzada, P.Roberto.F.; Afonso, R.C.; Meirelles, M.Nazareth.L.; Lent, R.; Neto, V.Moura.; Ferreira, Sérgio.T. 2001: Inhibition of Alzheimer's disease β-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy FASEB Journal 15(7): 1297-1299
Ishii, T. 1991: Amyloid (senile) plaques in Alzheimer's disease brain Nihon Rinsho. Japanese Journal of Clinical Medicine 49(4): 945-949
Bufill, E.; Blesa, R. 2006: Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy? Revista de Neurologia 42(1): 25-33
Goedert, M. 1987: Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease EMBO Journal 6(12): 3627-3632
Patterson, M.B.; Mack, J.L.; Mackell, J.A.; Thomas, R.; Tariot, P.; Weiner, M.; Whitehouse, P.J. 1997: A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. the Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11(Suppl 2): S40-S44
Yoshikawa, K.; Kametani, F. 1988: Recent trends in the molecular genetic approach to Alzheimer's disease--with special reference to amyloid protein precursors in the brain Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1508-1513
Yilmazer-Hanke, D.M. 1998: Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex Acta Anatomica 162(1): 46-55
Mastaglia, F.L.; Masters, C.L.; Beyreuther, K.; Kakulas, B.A. 1989: Deposition of Alzheimer's disease amyloid (A4) protein in the cerebral cortex in Parkinson's disease Progress in Clinical and Biological Research 317: 475-484
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Meena-Leist, C.E.; Parker, J.C. 1993: Amyloid deposition in Alzheimer's disease Annals of Clinical and Laboratory Science 23(3): 173-177
Mera, S.L. 1991: Aluminium, amyloid, and Alzheimer's disease Medical Laboratory Sciences 48(4): 283-295
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Gurwitz, D. 1996: Beta-Amyloid vasoactivity in Alzheimer's disease Lancet 347(9013): 1492
Storey, E.; Masters, C.L. 1995: Amyloid, aluminium and the aetiology of Alzheimer's disease Medical Journal of Australia 163(5): 256-259
Octave, J.N. 1995: The amyloid peptide precursor in Alzheimer's disease Acta Neurologica Belgica 95(4): 197-209